Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | +0.33% | +3.34% | -4.04% |
Apr. 30 | B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
Apr. 29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |